- OptiBiotix Health said it had entered into a three-year distribution agreement with Silv Expo for Russia and Kazakhstan.

The non-exclusive agreement would involve the distribution of the company's CholBiome products containing its cholesterol and blood pressure reducing LPLDL strain.

'We are pleased to announce this agreement which extends the sales of our CholBiome products into Russia and Kazakhstan where cardiovascular disease are the leading cause of morbidity and mortality,' commercial director Per Rehne said.

'We chose Silv Expo for its knowledge and speed to market and they have shown the ability to grow product sales in challenging markets.'

'This agreement is a strategic step to build the distribution sales channel for CholBiome products in Eastern Europe and we expect such agreements to be delivering earlier on revenues and that we would see the first sales in 2019.'

Story provided by